Enter assignee name

EPO Patents = 3

Trademarks = 4

Forward Citations = 13

Loading Chart...

10 inventors (with patents filed for the assignee):

Hawazin Faruki (9 out of 9 patents)

Myla Lai-Goldman (9 out of 9 patents)

Charles M Perou (9 out of 17 patents)

4. Greg Mayhew (8 out of 8 patents)

5. David Neil Hayes (7 out of 9 patents)

6. Jonathan Serody (4 out of 5 patents)

7. Gregory Mayhew (1 out of 1 patent)

8. Cheng Fan (1 out of 1 patent)

9. Mark Miglarese (1 out of 1 patent)

10. Joel S Parker (1 out of 5 patents)

11. Mark R Miglarese (0 patent)

9 patents: Sort by Forward Citations

1. 12195805 - Methods for subtyping of bladder cancer (2025-01-14),

2. 12139765 - Methods for subtyping of lung squamous cell carcinoma (2024-11-12),

3. 12139763 - Methods for subtyping of lung adenocarcinoma (2024-11-12),

4. 12006554 - Methods for subtyping of head and neck squamous cell carcinoma (2024-06-11),

5. 11851715 - Detecting cancer cell of origin (2023-12-26),

6. 11739386 - Methods for determining response to PARP inhibitors (2023-08-29),

7. 11041214 - Methods for subtyping of lung squamous cell carcinoma (2021-06-22),

8. 10934595 - Methods for subtyping of lung adenocarcinoma (2021-03-02),

9. 10829819 - Methods for typing of lung cancer (2020-11-10),

Genecentric Therapeutics, Inc. is a biotechnology company specializing in developing novel precision medicine therapies for cancer and other diseases. Through innovative genomics and computational biology approaches, the company identifies and targets key genes and pathways involved in disease progression. Genecentric Therapeutics aims to improve patient outcomes by providing personalized and effective treatment options.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

9 Patents

#29 in Research Triangle Park, NC

#657 in North Carolina

#31,684 in US

Research Triangle Park, NC, United States of America

Genecentric Therapeutics, Inc.